Elevance Health, Inc. P/E Ratio 2007–2025
Elevance Health, Inc. reported 13.76 of price-to-earnings ratio for fiscal 2025. That was 1.3% lower than fiscal 2024. Compared with fiscal 2020, the change was -16.7%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 13.76 | -1.3% |
| FY 2024 | 13.95 | -22.1% |
| FY 2023 | 17.92 | -10.4% |
| FY 2022 | 19.99 | +14.9% |
| FY 2021 | 17.39 | +5.3% |
| FY 2020 | 16.52 | +10.7% |
| FY 2019 | 14.92 | -10.6% |
| FY 2018 | 16.70 | +19.4% |
| FY 2017 | 13.98 | +1.9% |
| FY 2016 | 13.72 | +7.1% |
| FY 2015 | 12.82 | +8.2% |
| FY 2014 | 11.85 | +26.1% |
| FY 2013 | 9.40 | +54.2% |
| FY 2012 | 6.09 | -16.9% |
| FY 2011 | 7.33 | +13.2% |
| FY 2010 | 6.48 | +38.9% |
| FY 2009 | 4.67 | -33.3% |
| FY 2008 | 7.00 | -43.9% |
| FY 2007 | 12.48 | — |
Source: Elevance Health, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open ELV 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Elevance Health, Inc. reported 13.76 of price-to-earnings ratio for fiscal 2025. That was 1.3% lower than fiscal 2024. Compared with fiscal 2020, the change was -16.7%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Elevance Health, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeElevance Health, Inc. — frequently asked questions
What is Elevance Health, Inc.'s price-to-earnings ratio?
Elevance Health, Inc. (ELV) reported price-to-earnings ratio of 13.76 for fiscal year 2025, per its SEC filings.
How has Elevance Health, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2007 and 2025, ELV's price-to-earnings ratio grew at roughly 0.5% per year (compound annual rate), from 12.48 to 13.76.
Where does this data come from?
Figures are computed from Elevance Health, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More ELV financial history
Full ELV fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →